Search by Drug Name or NDC

    NDC 55566-1020-01 Ortikos 9 mg/1 Details

    Ortikos 9 mg/1

    Ortikos is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Ferring Pharmaceuticals Inc.. The primary component is BUDESONIDE.

    Product Information

    NDC 55566-1020
    Product ID 55566-1020_69c1e200-f5ae-429f-b890-b2418700a7e8
    Associated GPIs 22100012007030
    GCN Sequence Number 079892
    GCN Sequence Number Description budesonide CAPSULE ER 9 MG ORAL
    HIC3 P5A
    HIC3 Description GLUCOCORTICOIDS
    GCN 46497
    HICL Sequence Number 006545
    HICL Sequence Number Description BUDESONIDE
    Brand/Generic Brand
    Proprietary Name Ortikos
    Proprietary Name Suffix n/a
    Non-Proprietary Name Budesonide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 9
    Active Ingredient Units mg/1
    Substance Name BUDESONIDE
    Labeler Name Ferring Pharmaceuticals Inc.
    Pharmaceutical Class Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA211929
    Listing Certified Through 2023-12-31

    Package

    NDC 55566-1020-01 (55566102001)

    NDC Package Code 55566-1020-1
    Billing NDC 55566102001
    Package 30 CAPSULE in 1 BOTTLE (55566-1020-1)
    Marketing Start Date 2020-07-20
    NDC Exclude Flag N
    Pricing Information N/A